Barry S Zingman
Overview
Explore the profile of Barry S Zingman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
4190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knox J, Aharonovich E, Zingman B, Stohl M, Walsh C, Elliott J, et al.
AIDS Behav
. 2024 Mar;
28(6):1912-1922.
PMID: 38478322
Heavy drinking among people living with HIV (PLWH) reduces ART adherence and worsens health outcomes. Lengthy interventions are not feasible in most HIV care settings, and patients infrequently follow referrals...
2.
Mullis C, Marlow K, Maity A, Fazzari M, Zingman B, Keller M, et al.
Sex Transm Dis
. 2023 Dec;
51(3):199-205.
PMID: 38100794
Background: Mycoplasma genitalium (MG) is an emerging sexually transmitted infection. Treatment of MG is complicated by increasing resistance to primary treatment regimens, including macrolides and fluoroquinolones. Understanding the various clinical...
3.
Irshad U, Bishop D, Mullis C, Toro J, Zingman B, Meyerowitz E
Open Forum Infect Dis
. 2023 Nov;
10(11):ofad544.
PMID: 38023548
Mpox caused a global outbreak in 2022. Among 249 people who received mpox vaccination at a sexual health clinic in the Bronx, New York, those with private vs public insurance...
4.
Hasin D, Aharonovich E, Zingman B, Stohl M, Walsh C, Elliott J, et al.
J Subst Use Addict Treat
. 2023 Sep;
154:209148.
PMID: 37690290
No abstract available.
5.
Starbird L, Gutkind S, Teixeira P, Murphy S, Aharonovich E, Zingman B, et al.
J Stud Alcohol Drugs
. 2023 Jul;
84(6):814-822.
PMID: 37449954
Objective: Alcohol use among people living with HIV (PLWH) can reduce adherence and worsen health outcomes. We evaluated the economic cost of an effective smartphone application (HealthCall) to reduce drinking...
6.
Ortega-Villa A, Hynes N, Levine C, Yang K, Wiley Z, Jilg N, et al.
Open Forum Infect Dis
. 2023 Jun;
10(6):ofad290.
PMID: 37383244
Background: Clinical trials initiated during emerging infectious disease outbreaks must quickly enroll participants to identify treatments to reduce morbidity and mortality. This may be at odds with enrolling a representative...
7.
Meyerowitz E, Gendlina I, Desai V, Grossberg R, Nair S, Pujar B, et al.
Clin Infect Dis
. 2022 Oct;
76(5):934-937.
PMID: 36227656
We performed anorectal testing in 18 cis-gender men who have sex with men with symptoms consistent with mpox virus (MPXV) infection. We found rectal MPXV DNA in 9/9 with and...
8.
Meyerowitz E, Bernardo R, Collins-Ogle M, Czeresnia J, Matos C, Mullis C, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac191.
PMID: 35794936
Incident HIV infections occurring in people on PrEP may have delayed seroconversion. New CDC guidelines recommend the addition of HIV-1 viral load for screening for all on PrEP. We believe...
9.
Hasin D, Aharonovich E, Zingman B, Stohl M, Walsh C, Elliott J, et al.
J Subst Abuse Treat
. 2022 Feb;
138:108733.
PMID: 35131124
Introduction: Heavy drinking among people living with HIV (PLWH) worsens their health outcomes and disrupts their HIV care. Although brief interventions to reduce heavy drinking in primary care are effective,...
10.
Puius Y, Bartash R, Zingman B
Transpl Infect Dis
. 2021 Jul;
23(4):e13697.
PMID: 34324251
The widespread use of facemasks has been a crucial element in the control of the SARS-CoV-2 pandemic. With mounting evidence for mask efficacy against respiratory infectious diseases and greater acceptability...